Diabetes Care Devices Market Outlook To 2023 - Becton, Dickinson and Company, Dexcom, F. Hoffmann-La Roche, Johnson & Johnson, Medtronic, Novo Nordisk A/S, Terumo

The global diabetes care devices market was valued at $6,867 million in 2016, and is growing at a CAGR of 5.8% from 2017 to 2023 to reach $10,208 million by 2023. Diabetes care devices are used to check the blood glucose or the insulin level in a patient's body.

The major factor that contributes to the growth of the diabetes care devices market include the increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster and safer diagnosis and treatment of diabetes further boosts the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. In addition, adverse effects associated with some of the diabetes care devices also hinder the market growth.

Top Companies Covered in this Report:

Abbott Laboratories, ACON Laboratories, Inc., Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG), Becton, Dickinson and Company,Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Terumo Corporation

Get sample copy of Report at: https://bit.ly/36IsxSw

Diabetes care devices market is segmented on the basis of type and region. Based on type, the market is bifurcated into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices are categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices. Insulin delivery devices segment is further divided into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors.

By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Table of Contents

1: INTRODUCTION

2: EXECUTIVE SUMMARY

3: MARKET OVERVIEW

4: GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT

5: DIABETES CARE DEVICES MARKET, BY REGION

6: COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. ACON LABORATORIES, INC.

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. ASCENSIA DIABETES CARE HOLDINGS AG

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Key strategic moves and developments

6.4. BECTON, DICKINSON AND COMPANY

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. DEXCOM, INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

Purchase this report at: https://bit.ly/2M8TjKH

Sameer Joshi
Call: +912067274191
Email: sales@premiummarketinsights.com
Pune

About Premium Market Insights:
Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

This release was published on openPR.